Sysmex Inostics
Timo Sieber is a highly experienced professional in the field of research and development, specializing in in vitro diagnostics and viral vector development. Since August 2014, Timo Sieber has served as a Senior Scientist at Sysmex Inostics, focusing on flow cytometry applications and automated data analysis. Prior to this role, Timo Sieber worked at Universitätsklinikum Hamburg Eppendorf from December 2011 to August 2014 as a Wissenschaftlicher Angestellter, where responsibilities included development of cell type-specific viral vectors and project leadership for S2 level projects. Timo Sieber also held positions at Universität Hamburg and Heinrich-Pette-Institut, contributing to viral vector development and the investigation of tumor-inducing proteins in human adenoviruses. Timo Sieber holds a PhD in Biology from Universität Regensburg and a Dipl. Ing. in Biotechnology from Fachhochschule Weihenstephan Freising.
This person is not in any offices
Sysmex Inostics
Leaders of the Global Liquid Biopsy Revolution As pioneers in blood-based cell-free tumor DNA (ctDNA) mutation detection, Sysmex Inostics has provided custom assays and CLIA-certified lab services to leading BioPharma companies over the last 10 years with the overall goal: to develop therapeutics that extend lives and provide diagnostics to monitor response to therapy, identify targetable resistance alterations, and detect minimal residual disease (MRD). SafeSEQ NGS technology can detect clinically relevant mutations in circulating tumor DNA (ctDNA) with robust detection as low as 0.03% mutant allele frequency (MAF), thus ensuring reliable molecular information for real-time therapy selection as well as monitoring of tumor response from across a broader range of genomic regions.